About Veritura: A player cannot be the referee. It sells, sources and ranks none.
Limits computed. Every line cited.
The supplier vouches for its own paperwork. Every buyer checks it alone.
Federal law requires a valid certificate of analysis with every bulk substance used in compounding. Veritura checks each one, independently of the supplier that issued it.
United States Code21 U.S.C. §353a(b)(1)(A)(iii)
… accompanied by valid certificates of analysis for each bulk drug substance …
United States Code21 U.S.C. §353b(a)(2)(D)
… each accompanied by a valid certificate of analysis …
Checking the list is not checking the paper.
A distributor's reissue of a maker's certificate looks exactly like an original, and the pharmacist decides alone. Veritura was built to stand in that gap with nothing to sell.
Every pharmacy, facility, clinic and platform answers the validity question alone.
FDA described a bulk supplier on one of its own published lists labelling another facility's active ingredient as its own manufacture, and changing its dates.
A large telehealth provider began offering customers the certificate behind their medication in August 2024, by its own announcement. Who checks it is the question.
Valid becomes six checks. Each one a person can read.
The law asks for a valid certificate and stops there. Veritura turns the word into six checks, each cited to the line it rests on.
The certificate names the substance and the exact lot it describes.
The original manufacturer is named and registered with FDA to manufacture. A relabeler does not pass.
FDA DECRSA named person signed for the quality unit, because ICH Q7 asks for a person, not a role.
ICH Q7 11.4A distributor's reissue points back to the original maker's certificate.
Name, UNII, CAS number, formula and molecular weight match FDA's substance record.
FDA GSRSEvery result sits inside its own printed limit and inside the limits computed from USP <85>, ICH Q3C, ICH Q3D Class 1 and USP <1111>.
USP <85> · ICH Q3C · ICH Q3D · USP <1111>A version, an owner, a memory. A lot read today, explained next year.
A record only holds up if the rules it was read under can be named, and if nothing on it can be quietly changed.
The seller should not grade its own paperwork.
A supplier's portal can show you its certificate. It cannot be the party that tells you the certificate holds up, because it is the party that gains when it does.
A statement the supplier only typed in reads as Claimed, never as verified.
How each line is verifiedEvery review says which rules it was read under.
Reviewed outputs carry the methodology version that produced them: v1.1, published October 19, 2026, and v1.0, April 30, 2026, before it. A material change needs a new version and a visible record, so a lot read today can still be explained next year.
- Each check cites its statute section or chapter
- “Could not run” is said, with what it needs
Corrections are never silent.
A finding cannot be cleared by a signature. A corrected certificate runs the review again, and a person can set the older finding aside with a written reason. Both certificates and both readings stay on file.
- Every document kept with its SHA-256 fingerprint
- Every decision kept with who, when and why
No stake in the sale. No verdict for sale.
Independence is not a promise on a page. It is a list of things the business is built never to do, each one enforced in the product.
A finding never costs us a sale.
We never send an order to a pharmacy or take a share of one.
There is no league table.
A fee never awards a badge or changes an evidence result.
We read documents. We do not test material. Verified is a statement about the paperwork.
The release policy is the pharmacy's, and so is the signature.
Who stands behind the method.
Veritura LLC is independently owned and run. A question about a finding reaches the person who can change the method, never a rep.
Writes the method and the product, is accountable for every version, and runs the working sessions.
Input on how a finding reads at the bench.
Input on the statute, ICH and USP the checks cite. No advisor is quoted without written permission.
Specific about what it checks against.
Every check names the rule it rests on, so a reader can weigh the finding without taking our word for it.
Read the methodologyThe rules it rests on Statute, guidelines, chapters, registries
- FD&C Act 503A
- The three routes a substance may be compounded under, the named manufacturer and its registration, and the certificate itself.
- FDA's 503A lists
- 216.23(a), 216.23(b), Category 1 and Category 2, each name as FDA printed it on May 14, 2026, with the date shown.
- ICH Q7
- Signed for the quality unit by a named person, the testing laboratory named, and a distributor's reissue tied to the original.
- ICH Q3C and Q3D
- Residual solvents against 63 solvents and their exposure limits, and lead, cadmium, arsenic and mercury by route.
- USP <85> and <1111>
- The endotoxin limit computed from the pharmacy's own dose, K over M, and the microbial limits for total counts.
- FDA's own records
- The establishment registry, the substance registry (GSRS), enforcement records, warning letters, import alerts and the 503B list.
What “valid” becomes Checks a person can read
- Named
- The substance and lot are named.
- Made by a registered maker
- The original manufacturer is named and registered with FDA to manufacture.
- Signed
- A named person signed for the quality unit.
- Traced to the original
- A distributor's reissue points back to the original.
- Identified
- The identity matches FDA's substance record.
- Within its limits
- Every result sits inside its own limit and, where they apply, inside the limits computed from USP <85>, ICH Q3C, ICH Q3D Class 1 and USP <1111>.
How each line is verified Who stands behind it
- Matched at the issuer's public source
- Such as FDA's registry.
- Confirmed by the issuer in writing
- Such as the laboratory's reply.
- Checked at the source by a named person
- With a capture.
- Read from the issuer's own document
- Cited to its line.
- Computed
- Against the law or a published standard.
- Claimed
- A statement the supplier only typed in, never shown as verified. The same is true of a distributor reissuing a maker's certificate on its own letterhead, and of any marketplace paid on the order: none can grade its own paperwork.
Versions and signatures Nothing quietly changed
- Could not run
- A check that could not run is named and never counted as passed. A review that ran every check it could reads “Verified where checked”, and says what is missing.
- One signature chain
- Signatures carry a printed name, a time and a meaning, and they form one chain per workspace. A signature edited or removed afterwards breaks the chain, and the page says so.
The company Facts
- Company
- Veritura LLC
- Methodology
- v1.1, October 19, 2026
- Insurance
- $1M in professional liability (errors and omissions) coverage for the documentation work; it does not turn a report into a sign-off
- Data posture
- The server never receives a pharmacy's orders, patients or prescriber's words
- Write to us
- Through the contact page
Veritura verifies the paperwork behind compounded medicine: it computes the limits a certificate has to meet, checks it against FDA's own records and cites every line. It never tests, grades or endorses the medicine itself.
Questions, answered plainly.
No. Veritura does not sell, source or distribute any product, does not route orders, does not rank pharmacies or suppliers, and takes nothing from any order. That is the whole design.
Pharmacies and facilities pay for the workspace that runs their receiving, supplier files and release records, priced per site, and for Passports and Seals once per order when they select them. Suppliers and buyers use the Network free. Nobody pays for a result. How pricing works.
No. Supplier review is quoted work, and payment never awards a badge, improves placement or changes an evidence result. A pharmacy cannot pay to change what its published file says, and a finding it answers stays on the file, marked retired, with its date.
Veritura LLC is accountable for it, through one named methodology owner. Reviewed outputs carry the methodology version they were read under, now v1.1, dated October 19, 2026, and a material change requires a new version and a visible record. Read the methodology.
Send the report ID, the observation at issue and the document that supports the correction. It is reviewed against the source and the methodology version used. A correction changes the record and says that it changed; a response can be attached without erasing the original observation.
The server never receives a pharmacy's orders, patients or prescriber's words; the copy file stays with the pharmacy. The one exception is a patient who chooses to save the medicine from its scan page, which keeps that patient's email and serials until they delete it.
Still have questions? Talk to a person.